{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:31:56Z","timestamp":1790076716026,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,15]]},"DOI":"10.1097\/tp.0b013e3182848e03","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T19:42:48Z","timestamp":1369338168000},"page":"933-942","source":"Crossref","is-referenced-by-count":94,"title":["Randomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation"],"prefix":"10.1097","volume":"95","author":[{"given":"Diane","family":"Cibrik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio Tedesco","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anantharaman","family":"Vathsala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cornu-Artis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan G.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazi B.","family":"Zibari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad","family":"Shihab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation.","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1432-2277.2005.00080.x","article-title":"Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.","volume":"18","author":"Jardine","year":"2005","journal-title":"Transpl Int"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1034\/j.1600-6143.2003.00156.x","article-title":". Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation.","volume":"3","author":"Kramer","year":"2003","journal-title":"Am J Transplant"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":". Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"R5-6-20210129","first-page":"S3","article-title":"Clinical renal transplantation: where are we now, what are our key challenges Transplant P","volume":"42","author":"Chapman","year":"2010","journal-title":"roc"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/j.1600-6143.2007.01976.x","article-title":". Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids.","volume":"7","author":"Buchler","year":"2007","journal-title":"Am J Transplant"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1600-6143.2005.01177.x","article-title":". Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus.","volume":"6","author":"Larson","year":"2006","journal-title":"Am J Transplant"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5414\/CNP67164","article-title":". Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.","volume":"67","author":"Budde","year":"2007","journal-title":"Clin Nephrol"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1600-6143.2010.03129.x","article-title":". Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.","volume":"10","author":"Tedesco-Silva","year":"2010","journal-title":"Am J Transplant"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(10)62318-5","article-title":". Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.","volume":"377","author":"Budde","year":"2011","journal-title":"Lancet"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1432-2277.2004.tb00405.x","article-title":". Correlation between the Banff 97 classification of renal allograft biopsies and clinical outcome.","volume":"17","author":"Tanaka","year":"2004","journal-title":"Transpl Int"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/00007890-199706270-00006","article-title":". Absence of deleterious effect on long-term kidney graft survival of rejection episodes with complete functional recovery.","volume":"63","author":"Vereerstraeten","year":"1997","journal-title":"Transplantation"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.tp.0000188135.04259.2e","article-title":". Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant.","volume":"81","author":"Salvadori","year":"2006","journal-title":"Transplantation"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.transproceed.2009.02.036","article-title":". The first year renal function as a predictor of long-term graft survival after kidney transplantation.","volume":"41","author":"Helal","year":"2009","journal-title":"Transplant Proc"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.transproceed.2009.01.066","article-title":". First year renal function as a predictor of kidney allograft outcome.","volume":"41","author":"Resende","year":"2009","journal-title":"Transplant Proc"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.TP.0000061602.03327.E2","article-title":"Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation.","volume":"75","author":"Meier-Kriesche","year":"2003","journal-title":"Transplantation"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":". Antibody-mediated rejection criteriaan addition to the Banff 97 classification of renal allograft rejection.","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199506270-00007","article-title":". Predicting glomerular filtration rate after kidney transplantation.","volume":"59","author":"Nankivell","year":"1995","journal-title":"Transplantation"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":". A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":". National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3182848e03","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:31:14Z","timestamp":1620977474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201304150-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182848e03","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,15]]}}}